S100A11/ANXA2 belongs to a tumour suppressor/oncogene network deregulated early with steatosis and involved in inflammation and hepatocellular carcinoma development.
Cyril SobolewskiDaniel AbeggFlavien BerthouDobrochna DolickaNicolas CaloChristine SempouxMargot FournierChristine MaederAnne-Sophie AyPierre-Alain ClavienBostjan HumarJean-François DufourAlexander AdibekianMichelangelo FotiPublished in: Gut (2020)
Cellular stress associated with NAFLD triggers non-genomic alterations of a whole network of TSs/ONCs fostering hepatocarcinogenesis. Among those, overexpression of the oncogenic factor S100A11 promotes inflammation/fibrosis in vivo and is significantly associated with high-grade HCC with poor prognosis.